NCT04777721View on ClinicalTrials.gov

Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 17, 2022

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions
Tuberculosis
Interventions
BIOLOGICAL

BCG Danish

BCG Danish 1331 is on the WHO list of pre-qualified vaccines and has a well-defined side effect profile. BCG is licensed for delivery via the intradermal route. It is not licensed for delivery via the aerosol route.

Trial Locations (1)

OX37LE

Centre for Clinical Vaccinology and Tropical Medicine, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER